Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Mycoses ; 60(6): 412-415, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28205355

ABSTRACT

We describe two serious Trametes polyzona pulmonary infections, which occurred in Réunion Island, in critically ill patients. The identification was performed using sequencing of the internal transcribed spacer region of ribosomal DNA and D1/D2 region of 28S rDNA. In one case, the significance of T. polyzona in the pathological process was certain, proven by histopathological evidence of fungal lung infection. T. polyzona, an emerging filamentous basidiomycete, prevalent in tropical areas, has not been described so far in human infections.


Subject(s)
Lung Diseases, Fungal/diagnosis , Mycoses/diagnosis , Trametes/isolation & purification , Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Child, Preschool , DNA, Fungal/genetics , Female , Humans , Lung Diseases, Fungal/drug therapy , Male , Microbial Sensitivity Tests , Middle Aged , Mycoses/drug therapy , RNA, Ribosomal, 28S/genetics , Reunion/epidemiology , Sequence Analysis, DNA
2.
Neurology ; 86(1): 94-102, 2016 Jan 05.
Article in English | MEDLINE | ID: mdl-26609145

ABSTRACT

OBJECTIVE: To estimate the cumulative incidence rate (CIR) of Chikungunya virus (CHIKV)-associated CNS disease during the La Réunion outbreak, and assess the disease burden and patient outcome after 3 years. METHODS: CHIKV-associated CNS disease was characterized retrospectively in a cohort of patients with positive CHIKV reverse transcriptase PCR or anti-CHIKV immunoglobulin M antibodies in the CSF and fulfilling International Encephalitis Consortium criteria for encephalitis or encephalopathy. Neurologic sequelae were assessed after 3 years. RESULTS: Between September 2005 and June 2006, 57 patients were diagnosed with CHIKV-associated CNS disease, including 24 with CHIKV-associated encephalitis, the latter corresponding to a CIR of 8.6 per 100,000 persons. Patients with encephalitis were observed at both extremes of age categories. CIR per 100,000 persons were 187 and 37 in patients below 1 year and over 65 years, respectively, both far superior to those of cumulated causes of encephalitis in the United States in these age categories. The case-fatality rate of CHIKV-associated encephalitis was 16.6% and the proportion of children discharged with persistent disabilities estimated between 30% and 45%. Beyond the neonatal period, the clinical presentation and outcomes were less severe in infants than in adults. CONCLUSIONS: In the context of a large outbreak, CHIKV is a significant cause of CNS disease. As with other etiologies, CHIKV-associated encephalitis case distribution by age follows a U-shaped parabolic curve.


Subject(s)
Chikungunya Fever/diagnosis , Chikungunya Fever/epidemiology , Chikungunya virus , Encephalitis/diagnosis , Encephalitis/epidemiology , Adult , Aged , Cohort Studies , Female , Follow-Up Studies , Humans , Infant , Infant, Newborn , Male , Middle Aged , Prospective Studies , Retrospective Studies , Reunion/epidemiology
4.
Crit Care Med ; 36(9): 2536-41, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18679124

ABSTRACT

OBJECTIVE: To report the clinical and laboratory findings of adults with serious chikungunya virus acute infection hospitalized in an intensive care unit. DESIGN: Case series study from August 2005 to May 2006. SETTING: Medical intensive care unit, South Reunion Hospital. PATIENTS: We observed 33 episodes of confirmed acute chikungunya virus infection (chikungunya virus-IgM or reverse transcription-polymerase chain reaction positive in the serum) admitted to the intensive care unit. INTERVENTIONS: We collected cerebrospinal fluid, serum, and sometimes tissue samples from patients with suspected chikungunya fever in our intensive care unit. These samples underwent viral testing for evidence of acute chikungunya virus infection. MEASUREMENTS AND MAIN RESULTS: Of the 33 patients, 19 (58%) had chikungunya virus specific manifestations, 8 (24%) had associated acute infectious disease and 6 (18%) exacerbations of previous complaints. Among the chikungunya virus specific manifestations, we identified 14 cases of encephalopathy, one case each of myocarditis, hepatitis and Guillain Barré syndrome. Eighty-five percent of patients had a McCabe score = 1 (for nonfatal or no underlying disease). Mortality was 48%. CONCLUSIONS: Chikungunya virus infection may be responsible for very severe clinical presentation, including young patients with unremarkable medical histories. Chikungunya virus infection is strongly suspected to have neurologic, hepatic, and myocardial tropism leading to dramatic complications and high mortality rate.


Subject(s)
Alphavirus Infections/epidemiology , Chikungunya virus , Acute Disease , Adult , Aged , Aged, 80 and over , Alphavirus Infections/mortality , Alphavirus Infections/physiopathology , Disease Outbreaks , Enzyme-Linked Immunosorbent Assay , Female , Hospital Bed Capacity, 500 and over , Humans , Indian Ocean Islands/epidemiology , Male , Middle Aged , Reverse Transcriptase Polymerase Chain Reaction
5.
Clin Chem Lab Med ; 45(8): 993-5, 2007.
Article in English | MEDLINE | ID: mdl-17867987

ABSTRACT

BACKGROUND: Detecting and quantifying circulating free DNA in patient serum has become a major challenge. New methods using conventional or automated DNA amplification have been developed. As quantitative real-time PCR (QPCR) remains expensive and requires dedicated automated instrumentation, we questioned whether simple quantification using fluorescent dyes is efficient for determination of free DNA levels in serum. METHODS: Serum samples from 180 cancer patients and 58 healthy volunteers were used for DNA quantification according to three methods: (i) using an exonic part of the beta-globin gene as the amplifying target; (ii) amplifying a 105-bp intron 1 part of the housekeeping cyclophilin A gene, both referring to specific standard curves; and (iii) using a PicoGreen DNA quantification kit without amplification. RESULTS: The 58 samples from healthy controls showed a reference limit of (95th percentile) <160 cyclophilin gene copies/mL. The 180 cancer samples displayed values ranging between 300 and 215,000 copies/mL. The cyclophilin method showed a high level of correlation with both the beta-globin (r=0.911, p<0.0001) and PicoGreen (r=0.915, p<0.0001) methods. CONCLUSIONS: Aside from the disadvantage that the QPCR assays can only be used in clinical biochemistry laboratories that possess QPCR apparatus, the use of direct PicoGreen quantification displays major advantages in a routine context: it is less time-consuming and is quite inexpensive, but is still correlated with QPCR.


Subject(s)
DNA/analysis , Fluorescent Dyes , Polymerase Chain Reaction/methods , Reagent Kits, Diagnostic/standards , Adult , Aged , Case-Control Studies , Cyclophilins , Globins , Humans , Middle Aged , Neoplasms/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...